BIO — Biome Grow Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Biome Grow, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 4.68 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0.959 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 8.98 | 14.4 | 5.34 | 0.429 | 0.706 |
| Operating Profit | -8.98 | -9.69 | -5.34 | -0.429 | -0.706 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.86 | -9.75 | -1.72 | -0.14 | -10.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.86 | -9.48 | -1.72 | -0.14 | -10.9 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -8.86 | -9.48 | -0.239 | -0.14 | -10.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.86 | -9.48 | -0.239 | -0.14 | -10.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.057 | -0.054 | -0.018 | -0.007 | -0.096 |